文献速递前列腺癌前列腺增生与排尿功能障碍

机器人辅助根治性前列腺切除术围手术期数字化路径转型:对患者结局与依从性的影响

Transition to a digital perioperative pathway for robot-assisted radical prostatectomy: impact on patient outcomes and adherence.
PubMed 文献 · BJU Int · 2025-12-01

该研究在350例接受机器人辅助根治性前列腺切除术的患者中比较预康复与无预康复的效果,并评估从线下转为数字化路径后的项目参与率。预康复组6周控尿率84.2%显著高于对照组67.6%,数字化后参与率从26.6%升至68.7%。

要点

  • 预康复可提高机器人辅助根治性前列腺切除术后早期控尿率。
  • 数字化预康复路径可提高项目参与率且不降低效果。
  • 预康复未增加高级别并发症,安全性可接受。

核心结论

  • 预康复无论采用数字化还是数字化联合现场方式,均较无预康复改善早期控尿且不损害安全性。
  • 数字化提高了项目参与率,表明数字化预康复是有效且可扩展的选择。

研究设计与样本

  • 两中心、大容量、非随机前后对照连续队列,为期3年,共350例(对照组204例,预康复组146例)。
  • 预康复结合盆底肌训练、结构化教育和通过智能手机路径的优化,伴或不伴1天课程。

主要发现

  • 预康复组与对照组6周控尿率分别为84.2%与67.6%(P=0.003)。
  • 预康复组与对照组同日出院率分别为47.3%与35.3%(P=0.025)。
  • 预康复组与对照组高级别并发症(Clavien-Dindo≥III级)分别为2.1%与7.4%(P<0.001)。
  • 预康复组与对照组满意度评分均值(标准差)分别为9.4(0.7)与8.4(1.3)(P<0.001)。
  • 调整分析显示6周尿失禁 odds ratio 0.43(95%CI 0.22-0.85;P=0.015)。

关键数值与推荐

  • 主要结局为6周控尿(每天0-1片尿垫)。
  • 预康复组6个月控尿率97.7% vs 对照组84.3%(P<0.001),12个月99.2% vs 93.6%(P=0.004)。
  • 再入院率3.4% vs 7.8%(P=0.086)和计划外就诊3.4% vs 6.4%(P=0.218)无差异。
  • 项目参与率从现场时代的26.6%升至 successive 数字化时期的48.2%和68.7%(P<0.001)。

临床怎么用

  • 预康复可作为机器人辅助根治性前列腺切除术围手术期管理的一部分以改善早期控尿。
  • 数字化预康复路径可提高患者参与率,适合推广。

局限性

  • 非随机前后对照设计可能引入偏倚。
  • 两中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To test whether prehabilitation (PreHab), delivered digitally or as digital + on-site, improves early continence after robot-assisted radical prostatectomy (RARP) vs no PreHab, and to evaluate implementation by quantifying programme uptake after transitioning from an on-site programme to a digital pathway. PATIENTS AND METHODS: Two-centre, high-volume, non-randomised before-after consecutive cohort over 3 years (N = 350; Control = 204; PreHab = 146). PreHab combined pelvic floor muscle training, structured education, and optimisation via a smartphone pathway with or without a 1-day class. PRIMARY OUTCOME: 6-week continence (0-1 pad/day). SECONDARY OUTCOMES: same-day discharge (SDD), complications (Clavien-Dindo Grade ≥III), 30-day unplanned visits and readmissions, postoperative physiotherapy, satisfaction (0-10 visual analogue scale), and continence at 6 and 12 months. Group comparisons used chi-square/Fisher's and Mann-Whitney U; multivariable logistic regression provided adjusted estimates. RESULTS: For the PreHab vs Control cohorts: 6-week continence 84.2% vs 67.6% (P = 0.003); SDD 47.3% vs 35.3% (P = 0.025); high-grade complications 2.1% vs 7.4% (P < 0.001); mean (standard deviation) satisfaction score 9.4 (0.7) vs 8.4 (1.3) (P < 0.001). Readmissions 3.4% vs 7.8% (P = 0.086) and unplanned visits 3.4% vs 6.4% (P = 0.218) were not different. Continence remained higher with PreHab at 6 months 97.7% vs 84.3% (P < 0.001) and 12 months 99.2% vs 93.6% (P = 0.004). Adjusted analyses showed lower odds of 6-week incontinence (odds ratio 0.43, 95% confidence interval 0.22-0.85; P = 0.015). Uptake rose from 26.6% (on-site era) to 48.2% and 68.7% across successive digital periods (P < 0.001). Effects did not differ by delivery mode. CONCLUSIONS: Prehabilitation, regardless of delivery mode, improves early continence vs no PreHab without compromising safety; digitisation increased programme uptake, indicating that digital PreHab is an effective and scalable option.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Buhas BA, Uleri A, Katzendorn O, et al. Transition to a digital perioperative pathway for robot-assisted radical prostatectomy: impact on patient outcomes and adherence. BJU Int. 2025. PMID: 41327902. doi:10.1111/bju.70102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。